Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Ruthenium complexes revealed by Procept

May 31, 1996

Merck's pediatric pneumococcal conjugate vaccine in advanced trials

May 24, 1996

HPV vaccine in phase I at Merck & Co.

May 24, 1996

New finding may help in overcoming bacterial resistance

May 17, 1996

SKB and MicroCarb to collaborate on bacterial vaccines

May 17, 1996

Vical, Pasteur Merieux Connaught expand naked DNA vaccine collaboration

May 17, 1996

IMP dehydrogenase inhibitor synthesized at Roche Bioscience

May 17, 1996

CD45RB for organ transplant rejection

May 10, 1996

Cel-Sci announces promising results with TB vaccine

May 10, 1996

Axis Genetics scales up CVP production in anticipation of clinical trials

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...